Literature DB >> 25907692

Topical protection of human esophageal mucosal integrity.

P Woodland1, F Batista-Lima2, C Lee1, S L Preston1, P Dettmar3, D Sifrim4.   

Abstract

Patients with nonerosive reflux disease exhibit impaired esophageal mucosal integrity, which may underlie enhanced reflux perception. In vitro topical application of an alginate solution can protect mucosal biopsies against acid-induced changes in transepithelial electrical resistance (TER). We aimed to confirm this finding in a second model using 3D cell cultures and to assess prolonged protection in a biopsy model. We assessed the protective effect of a topically applied alginate solution 1 h after application. 3D cell cultures were grown by using an air-liquid interface and were studied in Ussing chambers. The apical surface was "protected" with 200 μl of either alginate or viscous control or was unprotected. The tissue was exposed to pH 3 + bile acid solution for 30 min and TER change was calculated. Distal esophageal mucosal biopsies were taken from 12 patients and studied in Ussing chambers. The biopsies were coated with either alginate or viscous control solution. The biopsies were then bathed in pH 7.4 solution for 1 h. The luminal chamber solution was replaced with pH 2 solution for 30 min. Percentage changes in TER were recorded. In five biopsies fluorescein-labeled alginate solution was used to allow immunohistological localization of the alginate after 1 h. In the cell culture model, alginate solution protected tissue against acid-induced change in TER. In biopsies, 60 min after protection with alginate solution, the acidic exposure caused a -8.3 ± 2.2% change in TER compared with -25.1 ± 4.5% change after protection with the viscous control (P < 0.05). Labeled alginate could be seen coating the luminal surface in all cases. In vitro, alginate solutions can adhere to the esophageal mucosa for up to 1 h and exert a topical protectant effect. Durable topical protectants can be further explored as first-line/add-on therapies for gastroesophageal reflux disease.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  esophageal mucosa; gastroesophageal reflux disease; topical mucosal protection

Mesh:

Substances:

Year:  2015        PMID: 25907692     DOI: 10.1152/ajpgi.00424.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  5 in total

1.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

2.  Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper.

Authors:  Mohd Adli Deraman; Muhammad Ilham Abdul Hafidz; Rona Marie Lawenko; Zheng Feei Ma; Mung Seong Wong; Cathal Coyle; Yeong Yeh Lee
Journal:  Aliment Pharmacol Ther       Date:  2020-04-28       Impact factor: 8.171

3.  The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study.

Authors:  Jie-Hyun Kim; Yong Chan Lee; Eun Hye Kim; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Da Hyun Jung; Jae Jun Park; Young Hoon Youn; Hyojin Park
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

Review 4.  Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art.

Authors:  Vincenzo Savarino; Elisa Marabotto; Patrizia Zentilin; Maria Giulia Demarzo; Nicola de Bortoli; Edoardo Savarino
Journal:  Drug Des Devel Ther       Date:  2021-04-19       Impact factor: 4.162

Review 5.  Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Authors:  Edoardo Savarino; Patrizia Zentilin; Elisa Marabotto; Gaia Pellegatta; Claudia Coppo; Matteo Brunacci; Pietro Dulbecco; Vincenzo Savarino
Journal:  Ann Gastroenterol       Date:  2017-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.